Research Reports

Q2 2025 module sales of 3.6 GW, above midpoint of prior forecast (CEO); net sales $1.1 billion, up $0.3 billion from Q1 (CFO)
Q2 earnings per diluted share $3.18, above high end of guidance range (CEO, CFO)
Q2 production: 4.2 GW total (2.4 GW U.S. facilities, 1.8 GW international) (CEO)
Gross margin Q2: 46%, up from 41% in Q1 (CFO)
Contract termination payments: $63 million in Q2, incl. $50 million related to 0.9 GW of terminated Series 6 international volume (CFO)
Section 45X tax credits: Q2 cumulative $29 million reduction to cost of sales; full-year guidance $1.58B–$1.63B, reduced ~$75 million due to assumed credit sale structure (CFO)
Capital expenditures Q2: $288 million, primarily for Louisiana facility (CFO)
Net cash position Q2 end: ~$0.6 billion; total cash & securities $1.2 billion (CFO)
Contracted backlog (June 30): 61.9 GW valued at $18.5 billion (~$0.299/watt); post-Q2 backlog 64 GW (CFO)
New bookings post-reconciliation bill: 2.1 GW (~1.4 GW Series 6 intl, ~0.7 GW at ~$0.32/watt excl. adjusters) (CFO)
Mid-to-late-stage booking pipeline: 20.1 GW; total pipeline 83.3 GW (CFO)
Tariff impact on finished goods imports: $80M–$130M net of contractual recoveries; bill of material tariffs ~$70 million (CFO)
Underutilization charges: $95M–$180M for full year; logistics costs increased $100M–$400M (CFO)

Official Guidance (FY2025):

Net sales: $4.9B–$5.7B
Gross margin: $2.05B–$2.35B (~42%)
Operating income: $1.53B–$1.87B (~32% margin)
EPS (diluted): $13.50–$16.50 (midpoint unchanged from prior)
CapEx: $1.0B–$1.5B (unchanged)
Year-end net cash: $1.3B–$2.0B
Q3 2025: module sales 5–6 GW; Section 45X credits $390M–$425M; EPS $3.30–$4.70
Module sales mix: U.S. manufactured 9.5–9.8 GW; international 7.2–9.5 GW (total 16.7–19.3 GW) (CFO, prepared)

Mgmt Quotes:

"Our Q2 earnings per diluted share came in above the high end of our guidance range at $3.18 per share." (CEO)
"We believe that the recent policy and trade developments have, on balance, strengthened First Solar's relative position in the solar manufacturing industry." (CEO)
"We are, on balance, pleased with the overall industrial and trade policy environment that has emerged over recent weeks." (CFO)
"The midpoint of our diluted EPS guidance remains unchanged, even with the approximately $0.70 of impact...which assumes the sale of 2025 Section 45X credits from all but one of our U.S. facilities." (CFO)
"Demand for our U.S. manufactured product remains strong." (CFO)

Metric	Value	Speaker/Context
Module sales (Q2)	3.6 GW	CEO
Production (Q2)	4.2 GW (2.4 GW U.S., 1.8 GW intl)	CEO
Net sales (Q2)	$1.1 B	CFO
Gross margin (Q2)	46%	CFO
EPS diluted (Q2)	$3.18	CEO, CFO
Contract termination payments (Q2)	$63 M	CFO
CapEx (Q2)	$288 M	CFO
Net cash (Q2 end)	~$0.6 B	CFO
Contracted backlog (Jun 30)	61.9 GW / $18.5 B	CFO
Post-Q2 backlog	64 GW	CFO
New bookings (post-reconciliation)	2.1 GW	CFO
Pipeline (mid/late-stage)	20.1 GW	CFO
FY25 net sales guidance	$4.9B–$5.7B	CFO
FY25 gross margin guidance	~42%	CFO
FY25 EPS guidance	$13.50–$16.50	CFO
FY25 CapEx guidance	$1.0B–$1.5B	CFO
FY25 year-end net cash guidance	$1.3B–$2.0B	CFO
FY25 U.S. module sales	9.5–9.8 GW	CFO
FY25 international module sales	7.2–9.5 GW	CFO
FY25 tariff on finished goods	$80M–$130M	CFO
FY25 tariff on BOM	~$70 M	CFO
FY25 underutilization charges	$95M–$180M	CFO
FY25 Section 45X credits	$1.58B–$1.63B	CFO
Q3 EPS guidance	$3.30–$4.70	CFO
Q3 Section 45X credits	$390M–$425M	CFO

Topic: July bookings surge and pricing drivers
Key points:
- July bookings exceeded 2 GW, including pent-up demand after OBBBA signing (July 4); safe harbor window extended through 2030.
- Pricing at $0.32–$0.33/W; attributed to safe harbor, FEOC, AD/CVD, and a customer whose Chinese supplier reneged on volume needed for 2026.
- Near-term pipeline of ~1 GW expected to close; management "filling their way through" price discovery.
Mgmt stance: Neutral — encouraged by pricing opportunity but still learning market dynamics; emphasizes "discovery" for where ASPs settle.

Topic: Booking composition and U.S. capacity pricing strategy
Key points:
- July bookings mainly Series 6 international and re-contracted volumes; no 2027+ U.S. Series 7 capacity committed yet.
- Re-contracted Series 6 cleared inventory, reducing warehousing/demurrage costs; safe harbor at inverter level seeds 2–3 GW follow-on per 200 MW committed.
- 232 polysilicon probe seen as potential catalyst; management being "very selective" on committing U.S. capacity.
Mgmt stance: Cautious — sees value in clearing inventory and seeding safe harbor, but awaiting better pricing clarity before tapping 2027–2030 U.S. capacity.

Topic: Pricing catalysts, inventory, and capacity expansion
Key points:
- Domestic content pricing could be "high 30s" (cents/W) if international at $0.32; UFLPA reinforcement and 232 are additional catalysts.
- Domestic supply contracted solid through 2028; considering U.S. finishing lines for Series 6/7 to cut tariff exposure (import value ~$0.10–$0.11 vs. $0.30s) and qualify for manufacturing tax credit.
- Site selection and tooling transfer from Malaysia/Vietnam being evaluated; tariff regime still uncertain (e.g., recent India-related info).
Mgmt stance: Bullish on strategic finishing line opportunity but cautious on timing — needs tariff and executive order dust to settle; "ready for this" with pre-work underway.

Topic: North America booking pipeline and demand drivers
Key points:
- North America booking opportunity pipeline up 1 GW (to ~3 GW if including July’s 2 GW), per Slide 7; industry-wide volume appears large for next few years.
- Customer with reneged Chinese supplier signed for 2026, now looking at "meaningfully larger" volumes for 2027–2028; hyperscaler/AI demand could be "incremental catalyst."
- Pipeline may reflect reallocation from disrupted supply chains, not necessarily net new demand.
Mgmt stance: Neutral — sees strong inbound but unsure if it’s incremental or just redistribution; notes difficulty distinguishing between the two.